Clinical Trial Update: Evaluation of IL-33 in Patients With the Acute Ischemic Stroke

View source ↗

Summary

A completed clinical trial evaluated interleukin-33 (IL-33) for acute ischemic stroke. The snippet does not include efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• IL-33 (Interleukin-33)

Snippet

Sponsor: Jan Biziel University Hospital No 2 in Bydgoszcz | Conditions: Ischemic Stroke | Status: COMPLETED